- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Medicines Co/The+ Add to Watchlist
MDCO:US29.8500 USD 0.2800 0.93%
As of 20:10:00 ET on 03/06/2014.
Company Profile for Medicines Co/The (MDCO)
The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.
Key Executives for Medicines Co/The (MDCO)
|Clive A MeanwellChairman/CEO||Glenn P SblendorioPresident/CFO|
|Paul M AntinoriSenior VP/Secy/Gen Cnsl||William B O'ConnorSenior VP/Chief Acctg Officer|
|Michael MitchellHead:Global Communications|